Allulose is a new lower calorie sugar in a category of new sweeteners referred to as “rare sugars.” Due to the availability of rare sugars and guidance from FDA that allows for positive labeling on the Nutrition Facts panel, manufacturers are racing to formulate new lower calorie and sugar foods. In this article for Today’s Dietitian titled, Introducing Allulose, I define this new sugar, discuss other rare sugars, review safety evaluation and detail how allulose is processed through the human body.
In late 2021 a new consensus report, The Management of Type 1 Diabetes in Adults, was published jointly by American Diabetes Association (in Diabetes Care) and European Study for Diabetes (EASD) (in Diabetologia). The report was developed by 14 content experts. The focus, interestingly, is on people 18 years of age and older.
Until recently the only ways to take insulin, other than using an insulin pump, was via traditional pens or vial and syringe. Due to engineering and technological innovation there’s a growing cadre of insulin delivery devices called connected insulin delivery devices. In this blog for T1D Exchange, I define “connected” devices and review the rationale for their need.
Precision medicine, precision nutrition – both terms and concepts for personalized health care are becoming popular. But do we know enough yet to apply these concepts, and related knowledge, to make personalized recommendations?
I was once again delighted to appear on the award-winning and well-known nutrition podcast, Sound Bites, hosted by fellow RDN and CDCES, Melissa Joy Dobbins. I appeared on this episode (#189) with Dr. John Sievenpiper, one of the smartest scientist/researchers today on the topic of added sugars and sugar substitutes